Mergers & Acquisitions
Aug. 27, 2013
Sullivan, Goodwin Procter handle Amgen's $10.4 billion buy
Sullivan & Cromwell LLP represented Thousand Oaks-based biotechnology giant Amgen Inc. in its $10.4 billion acquisition of Onyx Pharmaceuticals Inc. Onyx was advised by Goodwin Procter LLP in the deal, first announced Sunday.
Daily Journal Staff Writer
Sullivan & Cromwell LLP represented Thousand Oaks-based biotechnology giant Amgen Inc. in its $10.4 billion acquisition of Onyx Pharmaceuticals Inc. Onyx, headquartered in South San Francisco, was advised by Goodwin Procter LLP in the deal announced Sunday.
The boards of directors at both companies have unanimously approved Amgen's $125 per-share cash offer. The deal is the largest for th...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In